RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Trexquant Investment LP's Holding History (CIK: 0001633445)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 228,754 Value ($000) $1,116 Avg Close $5.25 Range $4.45 - $7.15

Q1 2023

Shares 200,366 Value ($000) $1,336 Avg Close $7.93 Range $6.40 - $9.73

Q4 2022

Shares 128,673 Value ($000) $992 Avg Close $9.81 Range $7.04 - $13.29

Q3 2022

Shares 11,800 Value ($000) $126 Avg Close $10.13 Range $7.48 - $14.18

Q2 2022

Shares 54,257 Value ($000) $442 Avg Close $6.69 Range $4.92 - $9.40

Q4 2021

Shares 12,050 Value ($000) $206 Avg Close $18.82 Range $15.25 - $23.86

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	228,754	$1,116	$5.25	$4.45 - $7.15
Q1 2023	200,366	$1,336	$7.93	$6.40 - $9.73
Q4 2022	128,673	$992	$9.81	$7.04 - $13.29
Q3 2022	11,800	$126	$10.13	$7.48 - $14.18
Q2 2022	54,257	$442	$6.69	$4.92 - $9.40
Q4 2021	12,050	$206	$18.82	$15.25 - $23.86